PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

In flies, a search for the essence of obesity

2010-11-03
(Press-News.org) Fruit flies that grow obese after eating a diet loaded with fat could lead the way to the core elements of obesity, according to researchers who report their findings in the November issue of Cell Metabolism, a Cell Press publication.

The findings also get at obesity's origins. The demonstration that flies do become obese on a high-fat diet (HFD), much as humans do, indicates that the ability to become obese goes way, way back, the researchers say.

"The capacity for obesity is evolutionarily ancient," said Sean Oldham of the Sanford-Burnham Medical Research Institute. "The capacity for this disease has been around for 500 million years."

"This gets at a fundamental question in metabolic research," added Rolf Bodmer, also of the Sanford-Burnham Institute. "Organisms must maximize survival under many conditions. It is harder to survive in times of scarcity. As a result, organisms may be poised to maximize their food intake. At the other extreme, this can lead to obesity. It may be that the propensity has always been there."

Fruit flies normally eat fruit, but they will consume fats readily if that is what is given to them. In the new study, Bodmer and Oldham's team fed flies a HFD consisting of 30 percent fat in the form of coconut oil. And the flies got fat.

Flies can only grow so big because they have a rigid exoskeleton, the researchers said. Nevertheless, they showed increases in the amount of body fat they carried. The obese flies also showed many of the familiar signs of obesity; they developed high triglycerides and disruptions in the balance between insulin and blood sugar, along with heart dysfunctions reminiscent of diabetic cardiomyopathies. Detailed studies of heart function in the flies revealed an increase in cardiac lipids, reduced cardiac contractility, blockages, and structural pathologies.

"Whether this directly relates to what we see in humans, we don't know," Bodmer said. "As in diabetic cardiomyopathy, the fly hearts become less efficient." It's not yet clear whether the same molecular pathways underlie the condition in both flies and humans, but that is a question they intend to address through further study.

The researchers did show that one well-studied pathway, known as insulin-TOR, plays an important role in the fly symptoms. Treatments that reduced the insulin-TOR activity prevented the accumulation of excess fat in the insects and protected their heart. Manipulation of the insulin signal in fat tissue or in the heart itself also had a protective effect.

"When we manipulate this pathway in the hearts of flies, they are still obese, but their heart is 'blind' to the systemic effects," Bodmer said. The finding suggests that treatments designed to alter insulin-TOR signaling in specific tissues might hold promise.

More broadly, the fly model may help to unravel the pathways that are central to obesity and the relationships among them. "Obesity is a complicated disease," Oldham said. Many tissues and genes are involved, and in mammals, it can be difficult to sort all that out. Given enough resources, researchers could knock out genes in the fly genome one by one in search of those that influence heart dysfunction or obesity itself, Bodmer added.

"The discovery of these HFD-induced obesity phenotypes in the Drosophila genetic model will permit a detailed dissection of obesity phenotypes, especially with regard to the cardiac lipotoxicity effects (and possibly mimicking aspects of diabetic cardiomyopathy)," the researchers wrote. "In particular, we can now attempt to understand the various contributions of insulin resistance, fat accumulation, and fatty acid oxidation to the HFD-induced obesity phenotypes, including timing requirements. In summary, the advent of the Drosophila HFD-induced obesity model opens up many new horizons to study deregulated processes and diseases of chronic lipid excess."

###

END



ELSE PRESS RELEASES FROM THIS DATE:

Liver hormone is a cause of insulin resistance

2010-11-03
Researchers have identified a hormone produced and secreted by the liver as a previously unknown cause of insulin resistance. The findings, in the November issue of Cell Metabolism, a Cell Press publication, suggest a new target for the treatment of insulin resistance and type 2 diabetes, the researchers say. "The current study sheds light on a previously underexplored function of the liver; the liver participates in the pathogenesis of insulin resistance through hormone secretion," said Hirofumi Misu of Kanazawa University Graduate School of Medical Science in Japan. ...

Tamiflu is more effective at relieving flu symptoms than a combination of tamiflu and relenza

2010-11-03
In adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less effective than oseltamivir monotherapy and not significantly more effective than zanamivir monotherapy. This key finding comes from a randomized, placebo-controlled trial— in adults presenting with influenza symptoms at general practices throughout France during the seasonal influenza epidemic in 2008-2009— carried out by Catherine Leport from the University of Paris, France, and colleagues, and reported in this week's PLoS Medicine. In ...

eHealth evaluation needs alternate approach

2010-11-03
In this week's PLoS Medicine Magazine, Trisha Greenhalgh and Jill Russell from the Queen Mary University of London discuss the relative merits of "scientific" and "social practice" approaches to evaluation and argue that eHealth evaluation is in need of a paradigm shift. They critique the previous PLoS Medicine series on evaluating eHealth, published in late 2009. INFORMATION:Funding: The ideas in this paper were developed during an independent evaluation of the UK Summary Care Record programme, funded by a research grant from the UK National Institute of Health Research ...

Doctors and drug companies are still too cozy

2010-11-03
David Henry discusses a recent research article in PLoS Medicine that suggests that relationships between doctors and drug companies are still too close. The research, by Geoffrey Spurling and colleagues, examined the relationship between exposure to promotional material from pharmaceutical companies and the quality, quantity, and cost of prescribing. David Henry's offers his Perspective in this week's PLoS Medicine Magazine. INFORMATION: Funding: The author received no specific funding for this article Competing Interests: The author has declared that no competing ...

Modify hospice eligibility for dementia patients, says Institute for Aging Research study

2010-11-03
BOSTON—The system for hospice admissions for patients with advanced dementia, which is a terminal illness, should be guided by patient and family preference for comfort, not estimated life expectancy, says a new study published in the Nov. 3 Journal of the American Medical Association by the Institute for Aging Research at Hebrew SeniorLife, an affiliate of Harvard Medical School. Currently, patients requesting hospice services must be certified by their physician to have six months or less to live, and must sign a statement choosing comfort care services in lieu of curative ...

Illnesses, injuries greatly increase chances of older adults developing new or worsening disability

2010-11-03
In a study examining the factors that play a role in an older adult's transition to disability, intervening illnesses and injuries that led to hospitalization or activity restriction were associated with worsening functional ability, especially among those who were physically frail, according to a study in the November 3 issue of JAMA, a theme issue on aging. Thomas M. Gill, M.D., of the Yale University School of Medicine, New Haven, Conn., presented the findings of the study at a JAMA media briefing at the National Press Club. Among older persons, disability in essential ...

Rate of falls in hospitals significantly reduced after use of intervention for fall prevention

2010-11-03
Use of a fall prevention tool kit, which included a fall risk assessment, patient-specific prevention plan, an educational handout and a poster for over the patient's hospital bed reduced the number of older patients with falls in hospitals, according to a study in the November 3 issue of JAMA, a theme issue on aging. Patricia C. Dykes, R.N., D.N.Sc., of Partners HealthCare System, Brigham and Women's Hospital and Harvard Medical School, Boston, presented the findings of the study at a JAMA media briefing at the National Press Club. "Falls are a public health problem ...

Comprehensive primary care programs treat older patients with chronic conditions

2010-11-03
In a review of comprehensive primary care programs for older adults with multiple chronic conditions, authors identified three models that appear to have the greatest potential for improving quality of care and life for these patients, while reducing or not increasing the costs of their health care, according to an article in the November 3 issue of JAMA, a theme issue on aging. Chad Boult, M.D., M.P.H., M.B.A., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, presented the findings of the study at a JAMA media briefing at the National Press Club. "Older ...

DHA 'fish oil' supplements do not seem to slow cognitive, functional decline in Alzheimer's disease

2010-11-03
Patients with mild to moderate Alzheimer's disease (AD) who received supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA), believed to possibly reduce the risk of AD, did not experience a reduction in the rate of cognitive and functional decline, compared to patients who received placebo, according to a study in the November 3 issue of JAMA, a theme issue on aging. Joseph F. Quinn, M.D., of Oregon Health and Science University and the Portland VA Medical Center, Portland, Ore., presented the findings of the study at a JAMA media briefing at the National ...

Fly study uncovers molecular link between obesity and heart disease

2010-11-03
VIDEO: Researchers show that obesity-induced heart disease can be prevented by reducing the activity of TOR, a nutrient-sensing protein that regulates molecular circuits involved in growth, metabolism and lifespan. Click here for more information. LA JOLLA, Calif., November 2, 2010 – It's no secret that obesity is hard on the heart. More than 30 percent of Americans are obese, and many of them are also at increased risk for cancer, diabetes and heart disease. However, there ...

LAST 30 PRESS RELEASES:

Global first: New Indigenous-led research initiative to revitalize legal orders

Transforming acoustic waves with a chip

When climate risk hits home, people listen: Study reveals key to engagement with disaster preparedness messaging

Major breakthrough against diabetes thanks to a microbial molecule that disarms inflammation

Silicon chips on the brain: Researchers announce a new generation of brain-computer interface

Getting rest is the best

Towards sustainable organic synthesis – Mechanochemistry replaces lithium with sodium in organic reactions

Wireless device ‘speaks’ to the brain with light

Greenhouse gases to intensify extreme flooding in the Central Himalayas

New study sheds light on Milky Way's mysterious chemical history

Could altering the daily timing of immunotherapy improve survival in people with cancer?

Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance

Using social media may impair children’s attention

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

[Press-News.org] In flies, a search for the essence of obesity